Pictet Asset Management Ltd. lowered its position in shares of INC Research Holdings, Inc. (NASDAQ:INCR) by 11.0% during the second quarter, according to its most recent filing with the SEC. The firm owned 553,523 shares of the company’s stock after selling 68,699 shares during the period. Pictet Asset Management Ltd.’s holdings in INC Research Holdings were worth $31,468,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the stock. TradeLink Capital LLC acquired a new stake in shares of INC Research Holdings during the first quarter worth about $789,000. Redmile Group LLC acquired a new stake in shares of INC Research Holdings during the first quarter worth about $29,059,000. Alambic Investment Management L.P. boosted its stake in shares of INC Research Holdings by 301.9% in the first quarter. Alambic Investment Management L.P. now owns 42,600 shares of the company’s stock worth $1,953,000 after buying an additional 32,000 shares during the last quarter. KCG Holdings Inc. acquired a new stake in shares of INC Research Holdings during the first quarter worth about $691,000. Finally, Foresters Investment Management Company Inc. acquired a new stake in shares of INC Research Holdings during the first quarter worth about $128,000. 98.70% of the stock is currently owned by institutional investors and hedge funds.

INC Research Holdings, Inc. (NASDAQ INCR) opened at 54.90 on Friday. The stock has a market capitalization of $2.97 billion, a price-to-earnings ratio of 33.64 and a beta of 1.42. The stock’s 50 day moving average is $56.98 and its 200-day moving average is $51.90. INC Research Holdings, Inc. has a 52-week low of $40.65 and a 52-week high of $61.10.

INC Research Holdings (NASDAQ:INCR) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.64 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.64. The firm had revenue of $258.10 million for the quarter, compared to the consensus estimate of $256.76 million. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The company’s revenue was down .3% on a year-over-year basis. During the same period last year, the firm earned $0.61 EPS. Equities research analysts anticipate that INC Research Holdings, Inc. will post $2.60 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.watchlistnews.com/pictet-asset-management-ltd-has-31-47-million-position-in-inc-research-holdings-inc-nasdaqincr/1473032.html.

A number of research analysts have recently commented on INCR shares. Zacks Investment Research upgraded shares of INC Research Holdings from a “sell” rating to a “hold” rating in a research report on Friday, May 5th. BidaskClub lowered shares of INC Research Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Wells Fargo & Company lowered shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 3rd. TheStreet upgraded shares of INC Research Holdings from a “c” rating to a “b-” rating in a research report on Monday, April 17th. Finally, KeyCorp upgraded shares of INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 price target for the company in a research report on Monday, June 5th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $63.79.

In other news, CEO Alistair Macdonald sold 10,555 shares of the firm’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $58.38, for a total transaction of $616,200.90. Following the sale, the chief executive officer now directly owns 83,935 shares in the company, valued at approximately $4,900,125.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Christopher L. Gaenzle sold 6,873 shares of the firm’s stock in a transaction on Friday, June 30th. The shares were sold at an average price of $58.32, for a total transaction of $400,833.36. Following the sale, the chief accounting officer now owns 47,450 shares in the company, valued at $2,767,284. The disclosure for this sale can be found here. 0.24% of the stock is owned by company insiders.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings, Inc. (NASDAQ:INCR).

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.